drugset

drugset / Trial / NCT01796938

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

NCT01796938 ↗

Phase 1 Completed 40 enrolled UCB BIOSCIENCES, Inc.

Non-randomizedParallel-groupOpen-label

Summary

To investigate the Pharmacokinetics (PK) of oral administered Lacosamide in renal impaired subjects and healthy subjects.

Timeline

Start: 2004-06
Primary completion: 2004-11
Completion: 2004-11

Publications

Cawello W, Fuhr U, Hering U, Maatouk H, Halabi A. Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide. Clin Pharmacokinet. 2013 Oct;52(10):897-906. doi: 10.1007/s40262-013-0080-7.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Lacosamide	Other / unclassified	100 mg	Oral

Indications